News - Sun Pharmaceutical Industries, Mergers & Acquisitions


Popular Filters

Briefs: Depomed drops Sefelsa after CRL: Sun Pharma stalking Meda?


US specialty drugmaker Depomed (Nasdaq: DEPO) says that Food and Drug Administration issued a complete…

DepomedMedaMergers & AcquisitionsMetabolicsNorth AmericaPharmaceuticalRegulationResearchSefelsaSun Pharmaceutical Industries

Sun Pharma gives up fight to take full control of Taro; Angel Biotech in administration


Israel-based Taro Pharmaceutical Industries (Pink Sheets: TAROF) and Indian drugmaker Sun Pharmaceutical…

Angel BiomedicalAngel BiotechnologyBiotechnologyFinancialMergers & AcquisitionsPharmaceuticalSun Pharmaceutical IndustriesTaro Pharmaceuticals

Takeda sells non-Colcrys URL Pharma generic business to Sun Pharma; Eisai divests Gliadel Wafer in USA


Japan's largest drugmaker, Takeda Pharmaceutical (TYO: 4502), has entered into a definitive agreement…

Arbor PharmaceuticalsColcrysEisaiGenericsGliadelMergers & AcquisitionsNorth AmericaOncologyPharmaceuticalSun Pharmaceutical IndustriesTakeda PharmaceuticalsURL Pharma

Sun Pharma to acquire DUSA Pharmaceuticals for $230 million


India's Sun Pharmaceutical Industries (SUN.BO) has entered into a definitive agreement to acquire US…

DermatologicalsDUSA PharmaceuticalsLevulanMergers & AcquisitionsPharmaceuticalSun Pharmaceutical Industries

Sun Pharma finally succeeds in Taro takeover with increased offer


Indian drugmaker Sun Pharmaceutical Industries (SUN: BO) says that it has now reached agreement to acquire…

GenericsMergers & AcquisitionsSun Pharmaceutical IndustriesTaro Pharmaceuticals

Sun Pharma offers to acquire remainder of Taro shares


Indian drugmaker Sun Pharmaceuticals (SUN: BO) has proposed to acquire the remaining shares of Israel-based…

GenericsMergers & AcquisitionsPharmaceuticalSun Pharmaceutical IndustriesTaro Pharmaceuticals

Back to top